NMPA accepts clinical trial application for monkeypox vaccine
chinadaily.com.cn |
Updated: 2023-07-14 19:44
Share
Share - WeChat
The National Medical Products Administration (NMPA) has, on Thursday, officially accepted the clinical trial application for the replication-deficient monkeypox vaccine developed by China National Pharmaceutical Group Corporation (Sinopharm) Beijing Institute of Biological Products.
- NPC deputy leads a cliffside village toward rural vitalization
- Elevated iron levels key to social anxiety
- John Lee Chi-kin: HK has great potential to develop into an intl education hub
- Radar system aids rail tunnel safety study
- New guidelines aim to protect tourists' rights
- Gansu rolls out chartered buses to ferry migrant workers directly to new jobs outside province
